Erdafitinib Impurity 1 | CAS 1346133-39-8 - Request Quote
Erdafitinib Impurity 1
| SZ CAT No: | SZ-E057003 |
| CAS No | 1346133-39-8 |
| Mol.F. | C20H19N5O2 |
| Mol.Wt. | 361.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Erdafitinib Impurity 1 is chemically N-(3,5-Dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-amine. Erdafitinib Impurity 1 is supplied with detailed characterization data compliant with regulatory guideline. Erdafitinib Impurity 1 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Erdafitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1346133-39-8
Purchase 1346133-39-8
Order 1346133-39-8
Enquire 1346133-39-8
price of 1346133-39-8
1346133-39-8 Supplier
1346133-39-8 Manufacturer
1346133-39-8 Exporter
buy high quality Erdafitinib Impurity 1
Purchase Erdafitinib Impurity 1
Erdafitinib Impurity 1 suppliers
Erdafitinib Impurity 1 manufacturers
Erdafitinib Impurity 1 price
Order Erdafitinib Impurity 1
Enquire Erdafitinib Impurity 1
Erdafitinib Impurity 1 cost
Erdafitinib Impurity 1 Supplier
Erdafitinib Impurity 1 Distributor
Erdafitinib Impurity 1 for Method Validation
Erdafitinib Reference Standard
Erdafitinib Impurity 1 for ANDA Filing
Erdafitinib Impurity 1 for Forced Degradation Studies
Erdafitinib Impurity 1 Identification Standards
Erdafitinib Impurity 1 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.